Drug Delivery · 2019 · 28 citations · 16 references
PharmacyPharmacologyBioavailabilityPharmaceutical FormulationPulmonary Drug DeliveryRespiratory DiseaseStability Of Pharmaceutical FormulationsSurfactantsChemical Stability TestingConcentrationHigh-performance Liquid ChromatographyHigh-performance Liquid Chromatography AnalysisPulmonary DistributionPulmonary Drug DistributionSupplement DosageSurface Tension Measurement
F-budesonide suspension was examined by a Nano/PET digital scan in rats. The Marangoni effect of Survanta, Curosurf, and budesonide was tested by digital high speed photography. For Survanta supplemented with budesonide, with a concentration ratio of ≥50, the surface tension-lowering activity was minimally affected. Similarly, the surface tension-lowering activity of Curosurf was not significantly affected by addition of budesonide, if the concentration ratio was ≥160. With these concentration ratios of both suspensions, HPLC analysis revealed no new compounds identified. Curosurf as compared to Survanta exhibited a significantly higher Marangoni effect. We conclude that with current dosage recommended for Survanta and Curosurf, both surfactant/budesonide suspensions are biophysically and chemically stable. Both surfactants can act as an effective vehicle for budesonide delivery.
16
Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia
P.M. Wong, Andrew Lees, Jacoba Louw et al. · European Respiratory Journal · 2008 · 312 citations · Full text
Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
PEDIATRICS · 2010 · 237 citations